CAS 10297-73-1 Puritas >99.0% (HPLC)

Description:

Chemical Name: 4′-(Methylsulfonyl)acetophenone

CAS: 10297-73-1

Puritas: >99.0% (HPLC)

Aspectus: Alba ad lux Yellow Crystal

High Quality, Commercial Production

Contactus: Dr

Mobile/Wechat/Whatsapp: +86-15026746401

E-Mail: alvin@ruifuchem.com

Mitte ad nos inscriptio

Product Detail

Product Tags

Descriptio:

Shanghai Ruifu Chemical Co., Ltd. est primarium fabrica et supplementum 4'-(Methylsulfonyl)acetophenone (CAS: 10297-73-1) cum qualitate alta.CoA praebere possumus, totius orbis partus, parvas et parvas quantitates in promptu habentes.Si interesse in hoc facto, singula informationes mittas mitte nobis numerum CAS, nomen productum, quantitatem nobis.Please contact: alvin@ruifuchem.com

Chemical Properties:

Nomen chemicum	4'- (Methylsulfonyl) acetophenone
Synonyma	4-(Methylsulfonyl)acetophenone;4-Methylsulphonylacetophenone;4-Methyi Sulfonyl Acetophenone;4-(Methyl Sulfonyl) Acetophenone;1-(4-(Methylsufonyl)phenyl)ethanone;1-[4-(Methylsulfonyl)phenyl]ethan-1-one;p-Acetylphenyl Methyl Sulfone;p-Methylsulfonylacetophenone;Impuritas A Etoricoxib (USP A Compone Related)
CAS Number	10297-73-1
CATTUS Number	RF2932
Stock Status	In Stock, Productio Capacity 20 Tons per Month
Formulae hypotheticae	C9H10O3S
M. Pondus	198.24
Liquescens punctum	126.0~ 129.0℃(lit.)
Periculum Classis	Irritant
HS Code*	29144000
Brand	Ruifu Chemical

Specifications:

Item	Specifications
Aspectus	Alba ad lux Yellow Crystal
Puritas / Analysis Methodus	>99.0% (GC)
Liquescens punctum	126.0~129.0℃
Aqua (auctore Karl Fischer)	<0.50%
Totalis immunditias	<1.00%
Infrared Imaginis	Conformat ut Structure
Proton NMR Spectrum	Conformat ut Structure
Test Standard	Enterprise Standard
Consuetudinem	Pharmaceutical intermedia

Sarcina & Repono:

sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris

Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine et humore

commoda:

Satis capacitas: sufficientes facilities et technici

Professional Service: One stop acquireing service

Altera Package: Custom sarcina ac titulus praesto

Ieiunium Delivery: Si intra stirpem, tres dies partus praestatur

Supple firmum: Esse rationabile stirpe

Technical Support: Technology solution praesto

Custom Synthesis Service: Range from P. to kilos

High Quality: Constitutus ratio completa qualitas certitudinis

FAQ:

Quam mercari?Quaeso contactumDr. Alvin Huang: sales@ruifuchem.com or alvin@ruifuchem.com

15 Years Experience?Plus quam XV annos experientiae habemus in fabricando et exportando amplis intermediis pharmaceuticis vel alchimicis pharmaceuticis amplis.

Mercatus principalis?Vendere mercatum domesticum, Americam septentrionalem, Europam, Indiam, Coream, Iaponicam, Australiam etc.

Commodi?Superior qualitas, parabilis pretium, officia professionalia et subsidia technica, ieiunium partus.

Qualitasfides?Qualitas strictioris temperantiae ratio.Pro instrumento analysi professionali includuntur NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, KF, ROI, LOD, MP, Claritas, Solubilitas, Microbialis limes test, etc.

Exempla?Pleraque producta praebent exempla gratuita pro qualitate aestimationis, sumptus naviculas a clientibus solvendos.

Factory Audit?Factory audit gratissimum.Quaeso ante constitutum.

MOQ?Nec MOQ.Parvus ordo placet.

Tempus adferendi? Si intus prosapia, tres dies partus praestatur.

Transportatio?Per Express (FedEx, DHL), ab Air, per Mare.

Documenta?Post servitium venditionis: COA, MOA, ROS, MSDS, etc. praeberi possunt.

Consuetudo Synthesis?Consuetudo synthesis officia praebere potest ad optimas investigationes tuas necessitates aptandas.

Pensio conditio?Proforma cautionis primum post confirmationem ordinis mittetur, informationes nostrae ripae inclusas.Payment by T/T (Telex Transfer), PayPal, Western Union, etc.

Applicatio:

4'-(Methylsulfonyl)acetophenone (CAS: 10297-73-1) magna est materia rudis et media adhibita in synthesi organica, pharmaceutica.4'- (Methylsulfonyl)acetophenone immunditia Etoricoxib (CAS: 202409-33-4), quae certa inhibitor est COX-2.Etoricoxib genus est cyclooxygenase-selectivum valde 2 (COX-2) inhibitoribus a comitatu Merck elaboratum.Primum probatum est Etoricoxib ut mercatum ingrediendi anno 2002 in UK, deinde nationes mercatoriae et regiones inter Unionem Europaeam, Asiam, Australiam et Americam Latinam, secuta est.Usque ad finem MMXIII, probatum est in 97 regionibus venalicium in regionibus late adhibitis in curatione OSTEOARTHRITIS (OA), arthritis rheumatoidis, spondylitis ankylosingis, dolor longus humilis, podagrae arthritis acutus, dysmenorrhea prima et dolor postoperative, et alia. morbis.Etoricoxib etiam in Taiwan et Hong Kong Sinarum forum ingressus est.Ingressa est in mercatum in continenti Sinensi anno 2008 probatis indiciis podagrae arthritis et OA acutis esse, et alia indicia prima esse dysmenorrhea in secundo dimidio anno MMXIV.